Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-053-90
Published April 22, 2020 · Recall initiated: March 18, 2020
Summary
FDA records drug Class II recall D-1234-2020, published April 22, 2020 and initiated March 18, 2020. Recalling firm: Aurobindo Pharma USA Inc.; Status: Terminated; Reported quantity: 26976 units; Lot: Lot #: 05319004A1, Exp. Date 03/2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
What to do
Voluntary: Firm initiated · Letter
Get an email if SIMVASTATIN has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- SIMVASTATIN
- Manufacturer
- Aurobindo Pharma USA Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 05319004A1, Exp. Date 03/2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASimvastatin Tablets USP 40 mg Rx Only, Packaged as: a) 90-count tablets NDC 16729-006-15, UPC 3 16729 00615 6;March 8, 2023
- FDASimvastatin Tablets USP 20 mg Rx Only, Packaged as: a) 90-count bottle NDC 16729-005-15, UPC 3 16729 00515 9;March 8, 2023
- FDASimvastatin Tablets USP 5 mg Rx Only, Packaged as: a) 90-count bottle NDC 16729-156-15, UPC 3 16729 15615 8;March 8, 2023
- FDASimvastatin Tablets, USP, 10 mg, Rx Only, Packaged as: a) 90-count bottle NDC 16729-004-15, UPC 3 16729 00415March 8, 2023
- FDALevetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279April 22, 2020
- FDAMirtazapine Tablets, USP 15mg, 30-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton,April 22, 2020
Questions about this recall
Was Simvastatin Tablets, USP 40mg 90-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 65862-053-90 recalled?
Yes. FDA published recall D-1234-2020 on April 22, 2020. Reported hazard: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: SIMVASTATIN.